“…This heterogeneity means that large numbers of patients are required to demonstrate an effect. (80) Third, the delivery of nutrition and micronutrients is frequently interrupted or poorly tolerated in ICU patients, thus resulting in decreased delivery of the agent being studied, especially if it is enteral. Fourth, in many studies of enteral and parenteral nutrients, many agents are frequently combined into one formula, and therefore the effect produced by a single agent cannot be determined.…”